Search

everythinglearnresearchcommunity

for

Search:↓

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

North American ginseng extract helped regrow hair in balding mice.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

PRP did not significantly regrow hair in alopecia areata totalis patients.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The document describes a rare case of IFAP syndrome, a genetic condition with symptoms of hair loss, light sensitivity, and scaly skin.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

New treatments focusing on immune pathways show promise for stubborn hair loss.

A 4-year-old boy with a rare type of rickets and hair loss improved in bone health but not hair growth after vitamin D and calcium treatment.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.